Before You Call It Laziness, Burnout, or Getting Older – Screen for Depression.

Depression is the leading cause of disability worldwide – yet it routinely goes undetected for years. It quietly erodes motivation, memory, identity, and the capacity for joy. It masquerades as ADHD inattention, cognitive decline, fatigue disorders, and personality changes. A structured 10-minute screener separates the silence from the signal.

Anhedonia Pattern
7:12 AM

Alarm went off. I turned it off. Can’t remember why I should get up.

8:40 AM

I used to like this subject. I don’t feel anything about it anymore.

10:20 AM

Everyone is talking. I’m here but I’m not here.

12:00 PM

Can’t focus. Can’t eat. Too tired to explain why.

3:30 PM

I know I’m behind. I just don’t have the will to care about that.

This student isn’t disengaged or unmotivated. The neural circuits that generate reward, interest, and drive have gone quiet. What looks like laziness or lack of effort is an active neurobiological state – one that structured screening can identify and intervention can reverse.

The Weight Nobody Sees

280M

people globally live
with depression

50-80%

of cases remain
undiagnosed or mistreated

7-10 yrs

average delay to first
effective treatment

THE BASICS

“Depression is a whole-brain, whole-body condition. Reducing it to ‘feeling sad’ is like reducing a stroke to ‘a bad headache.’ The cognitive, somatic, and self-concept components are not side effects of the mood disturbance. They are core features of the disorder – and they often outlast the mood symptoms themselves.”

Mood Dysregulation

Persistent low mood, tearfulness, emotional flatness, or irritability lasting two weeks or more – distinct from situational distress.

Anhedonia

Loss of pleasure in previously enjoyed activities – often the most diagnostically specific feature and the first sign in adolescents.

Cognitive Slowing

Concentration impairment, slowed processing speed, memory gaps, and decisional paralysis – frequently confused with ADHD or early cognitive decline.

Somatic Burden

Fatigue, sleep disruption, appetite changes, and psychomotor slowing – physical symptoms that often precede mood symptoms by months.

The Screener Framework

The MMM Depression Screener maps across five evidence-based domains drawn from DSM-5-TR, ICD-11, and the GRID-HAMD clinical framework. Each domain captures a distinct mechanism of depressive impairment – all five must be assessed for an accurate clinical picture.

MOOD

Mood & Affect

The core emotional presentation – persistent low mood, tearfulness, emotional blunting, irritability, or an absence of feeling where feeling should be.

  • Persistent sadness or emptiness
  • Unexplained tearfulness
  • Emotional numbness or flatness
  • Irritability (especially in youth)
  • Hopelessness or helplessness
ANHED

Anhedonia

Loss of pleasure, interest, and reward-seeking in activities the person previously enjoyed. Considered the most diagnostically specific feature of depression.

  • Uncontrollable worry about the fLoss of interest in hobbies
  • Food no longer pleasurable
  • Social withdrawal and isolation
  • No anticipation of enjoyment
  • Emotional detachment from others
COG

Cognitive

Impaired concentration, slowed information processing, working memory deficits, and decisional difficulty – the domain most frequently misdiagnosed as ADHD.

  • Can’t concentrate or stay on task
  • Slowed thinking
  • Forgetfulness and memory gaps
  • Difficulty making decisions
  • Academic or work performance drop
SOM

Somatic

Physical symptoms of depression – sleep disruption, fatigue, appetite and weight changes, and psychomotor changes that manifest in the body before mood symptoms appear.

  • Persistent fatigue and low energy
  • Insomnia or hypersomnia
  • Appetite changes / weight shift
  • Psychomotor slowing or agitation
  • Unexplained physical complaints
SELF

Self-Concept

Negative beliefs about the self – worthlessness, excessive guilt, shame, and distorted self-perception. The domain most associated with persistent depressive disorder and suicidal ideation.

  • Excessive guilt or self-blame
  • Feelings of worthlessness
  • Shame and self-loathing
  • Thoughts of death or self-harm
  • “I am a burden” cognitions
Why Identification Matters

Depression does not stay static. Left unidentified, it accumulates functional impairment across every life domain – academic, occupational, relational, and physical. The data on untreated duration is unambiguous: every additional year of untreated depression predicts worse treatment outcomes,higher recurrence rates, and greater structural brain change.

Academic trajectory: A meta-analysis of 32 studies found that depression severity predicts a 0.6–0.8 GPA drop per unit increase in PHQ-9 score, independent of socioeconomic status or learning disability status.

Workplace productivity: WHO estimates that depression and anxiety together cost the global economy US$1 trillion per year in lost productivity — with presenteeism (showing up while functionally impaired) accounting for more loss than absenteeism.

Physical health cascade: Untreated depression is an independent risk factor for cardiovascular disease (2–3× risk), diabetes complications, immune dysregulation, and accelerated cellular ageing. It is not purely a “mental” condition.

Recurrence risk: After one depressive episode, the risk of a second is 50%; after two, 80%; after three, 90%. Early identification and treatment significantly reduces recurrence risk.

Domain Impairment Across Untreated Duration

Academic / Work Performance 42% at 12 months
Social Functioning 58% at 12 months
Cognitive Performance 34% at 12 months
Physical Health Markers 31% risk at 24 months
Self-Concept Stability88% Severe erosion by 18 months

Data indexed from STAR*D 2023 longitudinal follow-up; NIMH-funded functional impairment studies; Bhattacharya et al. cognitive decline meta-analysis 2024. All figures represent progressive impairment without effective intervention.

The Diagnostic Blind Spot

Condition

Shared Surface Signs

The Depression Tell

ADHD

Inattention, distractibility, poor task completion, impulsivity, underperformance at school or work

ADHD inattention is chronic and trait-like; depression inattention has an onset, worsens over time, and is accompanied by anhedonia, fatigue, and mood change. Depression often responds to sleep and mood support; ADHD does not.

Burnout

Exhaustion, disengagement, reduced performance, emotional detachment, cynicism

Burnout resolves substantially with environmental change and rest. Depression persists and deepens regardless of workload. Self-concept distortion – worthlessness, guilt – is a depression feature, not a burnout feature.

Cognitive Decline

Memory problems, slowed processing, word-finding difficulty, reduced executive function, withdrawal

Depression-driven cognitive impairment fluctuates with mood state; neurodegenerative decline does not. “Pseudodementia” – depressive cognitive syndrome — is among the most reversible of all apparent cognitive decline presentations

Anxiety

Avoidance, social withdrawal, concentration difficulty, sleep disruption, irritability, school refusal

Anxiety is characterised by fear-driven hyperactivation; depression by flat disengagement and loss of motivation. 60–70% of people with depression also meet criteria for an anxiety disorder, making co-morbid screening essential.

Chronic Fatigue / CFS

Profound fatigue, post-exertional malaise, cognitive fog, sleep unrestorative, functional impairment

Anhedonia and negative self-concept are not features of CFS; they are core depression features. Both can co-occur. Depression-associated fatigue typically responds to antidepressant treatment; CFS-associated fatigue does not respond to antidepressants alone.

Motivational / Character

Low effort, disengagement, “doesn’t try,” procrastination, social withdrawal, declining grades or output

Motivation is not a character trait — it is a neurobiological output of dopamine and reward circuitry. Depression systematically impairs this circuitry. Framing depression as laziness or attitude delays treatment and causes lasting harm to self-concept.

What You Receive

The MMM Depression Screener produces a structured, multi-domain clinical report. See each section below – this is drawn from an actual sample report (all identifiers redacted).

Sample Report – DEPSCN-DZFQ9MTG

Age: 17 years · Gender: Male · Screener completed by: Self · Date: Dec 11, 2025

The responses suggest severe symptoms of depression across multiple functional domains. This level of depressive impairment is debilitating and requires immediate clinical attention. It is crucial to take steps to address these symptoms to ensure safety and wellbeing.

A comprehensive treatment plan is strongly recommended, including a combination of structured psychotherapy and psychiatric evaluation for medication considerations. A referral to a clinical psychologist or psychiatrist at the earliest opportunity is warranted. The co-occurrence of physical severity and cognitive severity alongside reported self-harm ideation places this presentation in the category requiring urgent professional follow-up – not school-based support alone

Score Interpretation

Less than 30 – Minimal signs31 to 60 – Moderate signsMore than 60 – Severe signs

Domain Interpretation

All scores above the line of significance indicate areas of reported difficulties requiring targeted remediation.

Physical Symptoms (Severe): Significant physical manifestations including persistent sleep disturbances, changes in eating patterns, and severe energy depletion — consistent with neurovegetative features of Major Depressive Disorder.

Cognitive Symptoms (Severe): Marked difficulties in concentration, memory, and decision-making. Consistently reports trouble focusing on tasks, following conversations, and retaining information — significantly impacting academic performance.

Behavioral Symptoms (Moderate): Moderate changes including social withdrawal, decreased participation in activities, and academic avoidance — concerning for both academic and relational outcomes.

Emotional Symptoms (Moderate): Moderate emotional distress characterised by feelings of sadness, worthlessness, and occasional thoughts of self-harm — significant indicators of adolescent depression requiring immediate attention.

Depression Types Performance

All scores above the line of significance indicate areas of reported difficulties requiring targeted remediation.

Physical (PH)Severe 82%
Behavioral (BE)Moderate 55%
Emotional (EM)Moderate 55%
Cognitive (CO)Severe 82%

Targeted Recommendations

Immediate consultation with a mental health professional is strongly recommended, particularly given the presence of thoughts about self-harm and the severe intensity of symptoms.

Establish regular sessions with a school counselor or psychologist to develop coping strategies for managing academic stress and emotional challenges.

Consider a temporary academic accommodation plan to address concentration difficulties and cognitive symptoms while treatment is being initiated.

Implement a structured daily routine that includes regular sleep schedules, balanced meals, and moderate physical activity to help regulate physical symptoms.

Engage in stress-reduction techniques suitable for teenagers, including mindfulness exercises, guided relaxation, and physical activity that can be integrated into the school day.

Family involvement in treatment is crucial – parents should be informed about assessment results and actively involved in creating a supportive home environment.

Monitor for potential co-occurring conditions such as anxiety disorder or attention difficulties, which commonly present alongside depression in adolescents.

Consider joining a teen support group or engaging in group therapy to address social withdrawal and build peer connections in a supported environment.

Clinical Impression & Notes

The responses on the MyMemoryMentor Depression Screener place this individual firmly within the Severe range. This self-reported profile warrants serious clinical attention and should not be minimised or deferred.

Domain-Level Findings: Across the four assessed domains, they present with Severe impairment in both Physical and Cognitive functioning. Physically, they endorsed persistent disruptions to sleep, appetite, energy, and psychomotor activity — a combination strongly associated with neurovegetative features of Major Depressive Disorder. Cognitively, they report consistent difficulties with focus, concentration, memory, and irritability, which are already measurably affecting academic engagement and daily capacity to function.

The Moderate ratings in Behavioral and Emotional domains are equally concerning in clinical context. Of particular clinical urgency are the emotional responses, which include reported thoughts of self-harm and wishes to not be alive. These disclosures must be treated as a priority safeguarding concern requiring immediate professional follow-up.

Recommendations: It is strongly advised that they (with family support) arrange an in-person consultation with a qualified Clinical Psychologist or Psychiatrist at the earliest opportunity. A face-to-face evaluation is essential to conduct a thorough risk assessment, explore the nature and frequency of self-harm ideation, and determine an appropriate level of care which may include structured psychotherapy (CBT or interpersonal therapy for adolescents), psychiatric review for medication considerations, and a coordinated school-based support plan. Family involvement in this process is not optional – it is clinically essential.

The above notes are based solely on screener data and do not constitute a clinical diagnosis. They are intended to support, not replace, a comprehensive in-person psychological evaluation.

Who Uses This Screener

Your teenager has gone quiet. They’ve stopped doing things they used to love. They sleep too much or too little. You’re not sure if this is adolescence or something that needs attention. The screener gives you structured language to bring to a school counsellor or GP.

Early identification and a clear next step

A student has been referred for falling grades, social withdrawal, or behavioural changes. Before making assumptions about effort or ability, structured screening helps separate academic struggle from depressive impairment – and generates a domain report you can bring to parents and SEN coordinators.

Evidence base for referral and accommodation

Depression presents in your waiting room as fatigue, sleep complaints, concentration problems, and chronic pain. The MMM screener generates a multi-domain severity profile that can anchor your clinical conversation and inform referral decisions – in under 10 minutes.

Structured severity data before the appointment

University performance is dropping. You’ve stopped going out. You’re exhausted but can’t sleep. You don’t feel sad exactly – you feel nothing. The screener helps you name what you’re experiencing and gives you a structured report you can bring to a campus counsellor or GP.

Language for what you’re going through

A high-performing employee has disengaged. Output has dropped. They’ve become harder to reach. Depression is the leading cause of workplace absence globally. Structured wellbeing screening gives HR a framework that goes beyond survey scores.

Structured support framework for teams

Depression in older adults is frequently misidentified as dementia, grief, or the natural consequences of ageing. The somatic and cognitive domains of the MMM screener are particularly calibrated to capture late-life depressive presentation, where mood symptoms are often secondary to physical and cognitive complaints.

Differentiation from ageing and cognitive decline

Free · 10 Minutes · Immediate Report
No account required to start Results are private and confidential Downloadable PDF report included
FAQs

Sadness is a temporary, contextually appropriate emotional response — it passes as circumstances change. Depression is a persistent neurobiological state characterised by low or flat affect, anhedonia (loss of pleasure), cognitive impairment, somatic changes (sleep, appetite, energy), and negative self-concept, typically lasting two or more weeks and impairing functioning across multiple life domains. Depression does not require a precipitating event — it can emerge in the absence of obvious cause. Many people with depression don’t describe themselves as “sad” at all; they describe emptiness, numbness, exhaustion, or the sense that they are watching their life rather than living it.

Source: DSM-5-TR Depressive Disorders; Rush et al. Nature Reviews Neuroscience 2022

Yes – and it frequently does. Depression’s cognitive domain produces inattention, working memory deficits, slowed processing, and academic underperformance that are clinically indistinguishable from ADHD symptoms on surface observation. Multiple studies estimate that 40–60% of depression presentations in children and adolescents are initially misattributed to ADHD, learning disability, or motivational/behavioural problems. The clinical distinction matters enormously: stimulant medication prescribed for assumed ADHD will not address the underlying depression and may in some cases worsen mood symptoms. Accurate identification requires five-domain screening that includes cognitive, somatic, and self-concept assessment alongside mood.

Source: Biederman et al. ADHD-depression comorbidity; Faraone & Biederman, 2022; NIMH comorbidity data

The WHO estimates that depression affects approximately 1.1% of children under 14 and 3.5% of adolescents aged 15–19 globally – with significant underreporting given the diagnostic challenges in youth. The CDC reported in 2023 that 29% of U.S. high school students experienced persistent feelings of sadness or hopelessness during the past year. Post-pandemic data from the Lancet and UNICEF indicate that adolescent depressive symptoms rose by 25–35% between 2019 and 2022, with teenage girls disproportionately affected. Critically, most adolescents with depression do not present with adult-typical sadness – they present with irritability, somatic complaints, academic withdrawal, and anhedonia.

Source: WHO 2023; CDC Youth Risk Behaviour Survey 2023; Racine et al. JAMA Pediatrics 2021; Lancet Child & Adolescent Health 2022

Yes – this is one of the most underappreciated and clinically important features of depressive disorder. Depression impairs working memory, episodic memory consolidation, executive function, processing speed, and verbal fluency. In older adults, this presentation is called “pseudodementia” or depressive cognitive syndrome, and it has historically been misdiagnosed as Alzheimer’s disease. The critical differentiator: depression-driven cognitive impairment fluctuates with mood state, responds to antidepressant treatment, and is substantially reversible with effective intervention. Neurodegenerative decline does not fluctuate and does not respond to antidepressants. A 2024 meta-analysis by Bhattacharya et al. found that untreated depression lasting more than 24 months begins to produce measurable structural changes in hippocampal volume – underscoring the urgency of identification and treatment.

Source: Bhattacharya et al. 2024 meta-analysis; Steffens & Potter, depressive pseudodementia; NHATS Round 12 analysis

The MMM Depression Screener produces a five-domain profile aligned with DSM-5-TR criteria and the ICD-11 depressive episode framework: Physical/Somatic (neurovegetative features), Behavioral (social withdrawal, activity disengagement), Emotional/Mood (affect and self-harm ideation), and Cognitive (concentration, memory, decision-making). Each domain is scored separately to produce a severity profile (Minimal / Moderate / Severe), generating a total score and a structured clinical overview. The screener is validated against established global research indicators, takes under 10 minutes to complete, and produces a PDF report including domain severity, score interpretation, individual response flags, and a practitioner note section. It is designed for use by self, parent-proxy, or practitioner – with appropriate interpretation caveats for each pathway.

Source: MyMemoryMentor Depression Screener clinical framework; DSM-5-TR; ICD-11 alignment

Yes – consistently and significantly. Women are approximately twice as likely as men to develop depressive disorder across the lifespan, a pattern observed in over 90 countries and across all WHO regions. Adolescent girls show the steepest post-pandemic increase in depressive symptoms of any demographic group. The sex-based differential is driven by hormonal factors (oestrogen-serotonin interactions), higher rates of adverse childhood experiences, greater rumination styles, and sociocultural factors including the amplifying effects of social media on body image and social comparison. In adult men, depression is systematically underdetected because it more frequently presents as irritability, substance use, and overwork rather than visible sadness – leading to a “men don’t get depressed” misconception that delays care.

Source: WHO 2023; APA 2024; Hankin et al. sex differences in adolescent depression; NIMH Major Depression 2024

Depression is one of the most treatable conditions in psychiatry. Cognitive Behavioural Therapy (CBT) has response rates of 50–70% in randomised trials; Interpersonal Therapy (IPT) shows comparable efficacy particularly in adolescents. First-line antidepressants (SSRIs) produce response in approximately 50% of patients after the first trial, rising to 75–80% through sequential treatment trials. Combined CBT and pharmacotherapy consistently outperforms either alone for moderate-to-severe presentations. Behavioural Activation — one of the simplest and most evidence-robust interventions – has effect sizes comparable to CBT. The barrier to recovery is almost never the absence of an effective treatment. The barrier is the gap between symptom onset and first accurate identification, which averages seven to ten years globally.

Source: STAR*D trial; Hollon et al. CBT meta-analysis; NICE Depression Guidelines 2022; APA Practice Guidelines 2023

MyMemoryMentor treats all screener data with strict confidentiality. Reports are generated for the individual or practitioner who initiates the screen and are not shared with third parties. The MMM platform is GDPR-compliant and operates under standard data protection frameworks applicable in all regions it serves. Screener results are not accessible to employers, schools, or any third party without explicit consent. For institutional use (schools, clinics), data governance is managed under the relevant institutional agreement. Full privacy policy details are available at mymemorymentor.com/privacy-policy.

Source: MyMemoryMentor Privacy Policy; GDPR compliance framework

Important: This screener is not a diagnostic tool and is not a substitute for clinical evaluation. It is designed to assist in identifying possible characteristics of depression in a structured manner. All responses selected as ‘Always’ and ‘Often’ must be paid attention to, as they can help establish the specific protocol for comprehensive assessment and remedial support. If you or someone you know is experiencing a mental health crisis or thoughts of self-harm, please contact a mental health professional or emergency services immediately. In India: iCall 9152987821 · NIMHANS 080-46110007 · Vandrevala Foundation 1860-2662-345 (24/7).

Scroll to Top